Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1

被引:113
|
作者
Meadows, D. Christopher
Sanchez, Tino
Neamati, Nouri
North, Thomas W.
Gervay-Hague, Jacquelyn
机构
[1] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[2] Univ So Calif, Sch Pharm, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA
[3] Univ Calif Davis, Sch Vet Med, Ctr Comparat Med, Davis, CA 95616 USA
[4] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA
关键词
HIV-1; HIV integrase; vinyl sulfones;
D O I
10.1016/j.bmc.2006.10.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a previous study, we prepared a small library of chicoric acid analogs that possessed both potent anti-integrase and antiviral activity. It was also shown that active compounds fell into one of two groups: those that inhibited an early stage in viral replication and those that inhibited at a later stage. In this study, a series of vinyl geminal disulfone-containing compounds possessing a range of ring substituents has been synthesized to probe the impact of structure on inhibitory mechanisms. Four active compounds were identified using HIV drug susceptibility assays. Three of the inhibitors possessing either no substituents or electron-withdrawing substituents on the aromatic rings led to high levels of cytotoxicity and antiviral activity. Intrigued by the potential implications of electronic effects on activity, we probed whether the active compounds could be nonspecifically reacting via 1,4-addition. To investigate this hypothesis, the compounds were incubated with glutathione and upon LUMS analysis, molecular ion peaks corresponding to both mono and double addition adducts were identified. Second, we synthesized analogs lacking the ability to participate in 1,4-addition and tested them for antiviral activity and cytotoxicity, and found the compounds inactive for both activities. Taken together, the studies reported herein suggest that compounds lacking electron-donating substituents on the aromatic ring are promiscuous acceptors of biological nucleophiles, whereas compounds possessing electron-donating substituents seem to resist addition or at least be more selective and significantly less toxic. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1127 / 1137
页数:11
相关论文
共 50 条
  • [31] Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro
    McPhee, F
    Caldera, PS
    Bemis, GW
    McDonagh, AF
    Kuntz, ID
    Craik, CS
    BIOCHEMICAL JOURNAL, 1996, 320 : 681 - 686
  • [32] Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
    Zhao, L
    Chmielewski, JA
    BIOPOLYMERS, 2003, 71 (03) : 397 - 397
  • [33] Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
    Zhao, L
    O'Reilly, MK
    Shultz, MD
    Chmielewski, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1175 - 1177
  • [34] Minimal core domain of HIV-1 integrase for biological activity
    Kim, DJ
    Lee, SK
    Oh, YT
    Shin, CG
    MOLECULES AND CELLS, 2000, 10 (01) : 96 - 101
  • [35] Indolyl aryl Sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: Role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity
    La Regina, Giuseppe
    Coluccia, Antonio
    Piscitelli, Francesco
    Bergamini, Alberto
    Sinistro, Anna
    Cavazza, Antonella
    Maga, Giovanni
    Samuele, Alberta
    Zanoli, Samantha
    Novellino, Ettore
    Artico, Marino
    Silvestri, Romano
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (20) : 5034 - 5038
  • [36] HIV-1 coreceptors and their inhibitors
    Ray, N.
    Dorns, R. W.
    CHEMOKINES AND VIRAL INFECTION, 2006, 303 : 97 - 120
  • [37] 2-HETEROCYCLIC INDOLE-3-SULFONES AS INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE
    YOUNG, SD
    AMBLARD, MC
    BRITCHER, SF
    GREY, VE
    TRAN, LO
    LUMMA, WC
    HUFF, JR
    SCHLEIF, WA
    EMINI, EE
    OBRIEN, JA
    PETTIBONE, DJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (05) : 491 - 496
  • [38] HIV-1 inhibitors and malaria
    Skinner-Adams, Tina S.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 143 - 144
  • [39] INHIBITORS OF HIV-1 PROTEASE
    MEEK, TD
    JOURNAL OF ENZYME INHIBITION, 1992, 6 (01): : 65 - 98
  • [40] HIV-1 protease inhibitors
    Eron, JJ
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S160 - S170